ORAL RITLECITINIB AND BREPOCITINIB IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS: CHRONIC THERAPY DATA FROM THE VIBRATO UMBRELLA STUDY

William Sandborn  1     Silvio Danese  2     Jaroslaw Leszczyszyn  3     Jacek Romatowski  4     Engin Altintas  5     Elena Peeva  6     Michael Vincent  6     Padmalatha Reddy  6     Christopher Banfield  6     Anindita Banerjee  6     Jeremy Gale  6     Kenneth Hung  6    
1 University of California San Diego, San Diego, United States
2 IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy
3 Melita Medical Center, Wroclaw, Poland
4 Provincial Complex Hospital, Bialystok, Poland
5 Mersin University, Mersin, Turkey
6 Pfizer Inc., Cambridge, United States

Topic
IBD, Nurses, Primary Care

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing